[Use of thymodepressin for treating autoimmune cytopenia]

Autor: Iu E, Vinogradova, I A, Zamulaeva, V V, Pavlov, E I, Selivanova, V I, Deĭgin, S G, Smirnova, N V, Orlova, A S, Saenko
Rok vydání: 2002
Předmět:
Zdroj: Terapevticheskii arkhiv. 74(8)
ISSN: 0040-3660
Popis: To study influence of thymodepressin on the course of autoimmune cytopenia.Thymodepressin is a new synthetic hemoregulatory dipeptide (gamma-D-Glu-D-Trp). It was used for the treatment of 22 patients with autoimmune cytopenia.Hemoglobin levels were elevated in autoimmune hemolytic anemia and platelet levels were high in idiopathic thrombocytopenic purpura. A thymodepressin course resulted in a fall of total lymphocyte count and activated CD3+CD69+ lymphocytes.The above results, safety, absence of toxicity and allergenicity, parenteral and intranasal useability open perspectives for further studies of therapeutic action of thymodepressin as an immunodepressant in autoimmune processes.
Databáze: OpenAIRE